Trial Profile
A Randomized, Double-Blind, Active Controlled Study to Evaluate the Immunogenicity of Quadrivalent LAIV in Children.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs MEDI 3250 (Primary)
- Indications Influenza virus infections
- Focus Pharmacodynamics
- 01 May 2012 Results presented at the 2012 Annual Meeting of the Pediatric Academic Societies.
- 23 Oct 2011 Results presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
- 23 Sep 2011 Actual end date changed from Jan 2011 to Dec 2010 as reported by ClinicalTrials.gov.